A Placebo-Controlled, Dose-Ranging Study Followed by a Placebo-Controlled, Repeated-Dose Extension of Anti-TNF Chimeric Monoclonal Antibody (cA2) in the Treatment of Patients With Active Crohn's Disease
收藏DataCite Commons2025-04-22 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004698/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the effectiveness and safety of anti-TNF chimeric monoclonal antibody (cA2) compared to placebo in patients with active Crohn's disease.
提供机构：
Vivli
创建时间：
2019-09-19
